Evidence map›Paper›PMID 38131935›Full record

ArticleGels (Basel, Switzerland)2023

The Formulation and Evaluation of

Adeola Tawakalitu Kola-Mustapha, Miracle Halima Aliu, Ronke Hadiyat Bello, Oluwakorede Joshua Adedeji, Yusuf Oluwagbenga Ghazali

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Adeola Tawakalitu Kola-MustaphaCollege of Pharmacy, Alfaisal University, Riyadh 11461, Saudi Arabia.ORCID 0000-0001-8281-470X
Miracle Halima AliuDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, University of Ilorin, P.M.B 1515, Ilorin 240101, Nigeria.
Ronke Hadiyat BelloDepartment of Pharmaceutical Microbiology and Biotechnology, University of Ilorin, P.M.B 1515, Ilorin 240003, Nigeria.
Oluwakorede Joshua AdedejiDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, University of Ilorin, P.M.B 1515, Ilorin 240101, Nigeria.
Yusuf Oluwagbenga GhazaliDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, University of Ilorin, P.M.B 1515, Ilorin 240101, Nigeria.ORCID 0000-0001-6977-5611
University of Ilorin · NGAlfaisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global concern regarding the occurrence of antifungal resistance to synthetic conventional azoles used for treating vulvovaginal candidiasis, along with the associated side effects, is significant. Consequently, the pursuit for substitutes such as natural therapies has ensued. Essential oils, derived from plants, have been extensively researched and found to possess antibacterial and antifungal properties. This study aimed to assess the antifungal efficacy of two essential oils, both alone and in combination, against

Indexed as

Cymbopogon flexuosusemulgelMelaleuca alternifoliavulvovaginal candidiasis

Identifiers

PMID38131935
PMCPMC10743309
OpenAlexW4389286657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.